Dojolvi is usually taken orally in the form of a liquid. The general instructions for use are as follows:

• Measure the dose carefully using the provided measuring device.

• Take it with food to help with absorption.

• Divide the dose as prescribed by your healthcare provider, typically into two doses per day.

• Shake the bottle well before use to ensure the medication is evenly mixed.

• Store the medication as directed, usually at room temperature, and away from excessive heat or moisture.

If a dose is missed, take it as soon as possible unless it’s close to the time for the next dose. Do not take two doses at once to make up for a missed dose.

Doxorubicin works by targeting cancer cells at the DNA level. It affects the cancer cell’s ability to divide and grow in several ways:

1. Inhibiting DNA Replication: Doxorubicin blocks topoisomerase II, an enzyme necessary for the process of DNA replication. By inhibiting this enzyme, Doxorubicin prevents cancer cells from replicating and producing new cells.
   
   
2. Interfering with Transcription: Doxorubicin also inhibits RNA synthesis, the process by which genetic information is transferred from DNA to RNA. Without RNA, the cancer cell cannot produce the proteins needed for its survival and function.
   
   
3. Inducing Cell Death: Doxorubicin triggers apoptosis, a process where cancer cells essentially “self-destruct” due to the damage caused to their DNA. This results in the slow killing of the tumor cells.
   
   

The drug works most effectively against rapidly dividing cells, which is why it is effective against many types of cancer. However, because it can affect healthy cells that divide quickly (such as those in the bone marrow, gastrointestinal tract, and hair follicles), it also causes significant side effects.

Like many chemotherapy drugs, Doxorubicin has several potential side effects. These side effects can range from mild to severe, and not everyone will experience them. The most common side effects include:

Common Side Effects:

• Hair Loss (Alopecia): One of the most noticeable side effects, hair loss often occurs within a few weeks of starting treatment.
  
  
• Nausea and Vomiting: Doxorubicin can cause nausea and vomiting, though anti-nausea medications are often given alongside chemotherapy to manage this symptom.
  
  
• Fatigue: Many people feel extremely tired or weak during treatment.
  
  
• Mouth Sores: Doxorubicin can cause painful sores in the mouth and throat, making eating and swallowing difficult.
  
  
• Low Blood Counts: Doxorubicin can suppress bone marrow function, leading to low red blood cell count (anemia), low white blood cell count (neutropenia), and low platelet count (thrombocytopenia), which can increase the risk of infections, bleeding, and fatigue.
  
  

Serious Side Effects:

• Cardiotoxicity: One of the most serious side effects of Doxorubicin is its potential to damage the heart. This can lead to heart failure, particularly with higher cumulative doses. Regular monitoring of heart function (via Echocardiograms or Ejection Fraction Tests) is essential during treatment.
  
  
• Liver Damage: Doxorubicin can also cause liver toxicity, leading to symptoms like jaundice (yellowing of the skin or eyes), dark urine, and elevated liver enzymes.
  
  
• Infections: Because Doxorubicin suppresses the immune system by lowering white blood cell counts, patients are at a higher risk for infections.
  
  
• Severe Allergic Reactions: Although rare, Doxorubicin can cause severe allergic reactions, with symptoms like rash, swelling, or difficulty breathing. If any signs of an allergic reaction appear, medical attention is necessary immediately.
  
  
• Extravasation: If Doxorubicin leaks out of the vein (extravasation) during an IV infusion, it can cause severe tissue damage. This can result in redness, swelling, pain, and even ulceration in the area where the drug leaked out.
  

Before starting Doxorubicin, there are important precautions to keep in mind:

• Heart Health: Patients with pre-existing heart conditions should inform their healthcare provider, as Doxorubicin can cause cardiotoxicity (damage to the heart). It may not be suitable for people with certain heart conditions, such as congestive heart failure.
  
  
• Pregnancy and Breastfeeding: Doxorubicin can cause harm to a developing fetus and should not be used during pregnancy. Women should avoid becoming pregnant during treatment and for some time afterward. It is also not recommended for breastfeeding.
  
  
• Liver Problems: Patients with liver disease or impaired liver function should use Doxorubicin with caution, as it is metabolized in the liver and can worsen liver damage.
  
  
• Infections: Since Doxorubicin can lower white blood cell counts, it is important to monitor for signs of infection. Patients should avoid close contact with people who have infections, and seek medical attention if any signs of infection develop.
  
  
• Low Blood Counts: Regular blood tests are required to monitor the levels of blood cells, particularly during the first few weeks of treatment.
  

Doxorubicin can interact with several medications, which may increase the risk of side effects or decrease the effectiveness of the drug. Some important interactions include:

• Other Chemotherapy Drugs: When used with other chemotherapy drugs, especially those that affect the bone marrow, the risk of bone marrow suppression (a decrease in red and white blood cells and platelets) is increased.
  
  
• Heart Medications: Doxorubicin can cause cardiotoxicity (heart damage), so using it with drugs that already affect the heart (like trastuzumab or cyclophosphamide) can increase the risk of heart problems, including heart failure.
  
  
• Anticoagulants (Blood Thinners): Doxorubicin may interact with blood-thinning medications like warfarin, increasing the risk of bleeding.
  
  
• Liver Function: Doxorubicin is metabolized by the liver, and medications that affect liver enzymes (like certain antifungals, antibiotics, or HIV medications) can alter the drug’s effectiveness and increase side effects.
  
  
• Corticosteroids: Medications such as prednisone may increase the risk of certain side effects, including weight gain and fluid retention.
  

The dosage of Doxorubicin depends on several factors, including the type of cancer being treated, the patient’s medical condition, and whether the drug is being used alone or in combination with other chemotherapy agents. It is typically administered by intravenous (IV) infusion in a clinical setting under the supervision of a healthcare provider.

• For Breast Cancer: A typical dose is 60–75 mg/m² (body surface area) administered once every 3 weeks.
  
  
• For Leukemia: The dose varies depending on the specific type of leukemia being treated, but it is often 45 mg/m² per week.
  
  
• For Lymphoma: A typical dose is 50 mg/m² administered every 21 days.
  
  

The dosage and treatment schedule will be tailored to the individual’s response to treatment, their health condition, and the side effects they experience. Your healthcare provider will closely monitor your progress with regular lab tests to adjust the treatment as needed.

Doxorubicin is a prescription-only medication and must be administered by a healthcare professional. It is not available for self-administration due to the complexity of its use and the potential side effects. Treatment is usually given in a hospital or clinic setting where patients can be closely monitored for side effects.

1. What is doxorubicin used for?

• Doxorubicin is a widely used chemotherapy agent for various cancers, including breast, ovarian, bladder, stomach, thyroid, thyroid, and blood cancers, often as part of combination regimens.

2. What is the active ingredient in doxorubicin products?

• Doxorubicin hydrochloride (the active cytotoxic anthracycline).

3. How does doxorubicin work in the body?

• It intercalates DNA and inhibits topoisomerase II, preventing DNA replication and triggering cancer cell death.

4. What forms does doxorubicin come in?

• Injectable IV formulation (solution or vial); sometimes in liposomal forms (e.g., liposomal doxorubicin) for specific cancers.

5. How is doxorubicin administered?

• Intravenous infusion, typically over a set period, on a schedule (e.g., every 2–3 weeks) as part of a treatment protocol.

6. How long does it take to see benefits from doxorubicin?

• Response depends on cancer type and regimen; some patients respond within a few cycles.

7. What are common side effects?

• Nausea/vomiting, hair loss, fatigue, low blood counts, mucositis, mouth sores, hand-foot syndrome (less common with some regimens), fever.

8. Are there serious risks with doxorubicin?

• Yes: cardiotoxicity (potentially irreversible heart damage), myelosuppression, liver toxicity, kidney toxicity, infusion reactions, and secondary malignancies with prolonged use.

9. Can doxorubicin interact with other medications?

• Yes; interacts with other chemotherapy, radiotherapy, certain antibiotics, anticoagulants, and drugs that affect heart function. Discuss all meds with your oncology team.

10. Is doxorubicin safe during pregnancy?

• Doxorubicin can cause fetal harm; generally avoided during pregnancy unless clearly needed with specialist guidance.

11. How is cardiac risk monitored with doxorubicin?

• Baseline and periodic monitoring of heart function (Ejection Fraction via echocardiogram or MUGA scan), and monitoring for symptoms of heart failure.

12. How should doxorubicin be stored?

• Stored per product instructions, typically refrigerated or at room temperature as specified; protect from light if required.

13. Can children receive doxorubicin?

• Yes, in pediatric oncology under specialist protocols; dosing and safety are tailored to age and weight.

14. What should I do if I miss a dose?

• Contact your oncologist; do not double the dose. Follow the study or treatment protocol.

15. What are signs of an infusion reaction?

• Fever, chills, flushing, rash, shortness of breath, or chest tightness; report immediately.

16. How is doxorubicin different from other chemotherapies?

• It is an anthracycline with distinctive cardiotoxic risk; used in many regimens; often given with cardioprotective strategies in some contexts.

17. Can doxorubicin cause hair loss?

• Yes, temporary hair loss is common.

18. What should I tell my doctor before starting doxorubicin?

• All medications and supplements, pre-existing heart disease, liver/kidney disease, previous anthracycline exposure, prior radiation, pregnancy status, and allergies.

19. Is there a risk of secondary cancers with doxorubicin?

• Long-term chemotherapy exposure carries a risk; discuss with your oncologist.

20. Where can I find more information or support during treatment?

• Your oncology team, cancer support groups, patient information resources from cancer organizations.